https://www.selleckchem.com/pr....oducts/3,4-dichlorop
Evidence is limited for pulmonary surveillance. Contralateral prophylactic mastectomy (CPM) is not recommended for average-risk women with breast cancer due to lack of evidence for survival benefit, yet recent studies demonstrate increasing CPM rates. We identified patients with breast cancer treated with unilateral mastectomy (UM) with or without CPM. Rates of malignancy in CPM specimens and factors in CPM rates were assessed. From 2013 to 2017, 1353 patients had UM and 355 had CPM. Our institution's occult ma
Like
Comment
Share
